Filing Details

Accession Number:
0001493152-20-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-02 16:26:54
Reporting Period:
2019-12-30
Accepted Time:
2020-01-02 16:26:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1408443 Milestone Pharmaceuticals Inc. MIST Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1493215 Rtw Investments, Lp 412 West 15Th Street, Floor 9
New York NY 10011
No No Yes No
1493280 Roderick Wong C/O Rtw Investments, Lp
412 West 15Th Street, Floor 9
New York NY 10011
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2019-12-30 1,333 $15.48 3,936,826 No 4 P Indirect By RTW
Common Shares Acquisiton 2019-12-31 21,438 $15.50 3,958,264 No 4 P Indirect By RTW
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By RTW
No 4 P Indirect By RTW
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $15.4350 to $15.4958. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the full information regarding the number of shares and prices at which the transaction was effected.
  2. The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd., RTW Venture Fund Limited and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Each of RTW and Dr. Wong disclaim beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein.